Skip to main content
SpringerLink
Log in

Kardiovaskulär wirksame Medikamente und mechanische Kreislaufunterstützung

  • Chapter
Repetitorium Intensivmedizin

  • 8024 Accesses

Zusammenfassung

Bei kardiovaskulär wirksamen Medikamenten handelt sich hier um eine Vielzahl von Substanzen mit uneinheitlicher chemischer Struktur und mit unterschiedlichen pharmakologischen Wirkmechanismen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aragon J, Lee MS, Kar S et al (2005) Percutaneous left ventricular assist device: »TandemHeart« for high-risk coronary intervention. Catheter Cardiovasc Interv 65: 346–352

    Google Scholar 

  • Cheng JM et al. (2009) Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 30: 2102–2108

    Google Scholar 

  • De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; Investigators SOAP II (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779–789

    Google Scholar 

  • Erdmann E (2009) (Hrsg.) Klinische Kardiologie Krankheiten des Herzens, des Kreislaufs und der herznahen Gefäße, 7. Aufl. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Ferrari M, Figulla HR (2005) Circulatory assist devices in cardiology. Dtsch Med Wochenschr 130:652–656

    Article  CAS  PubMed  Google Scholar 

  • Ferrari M, Poerner TC, Brehm BR et al (2008) First use of a novel plug-and-play percutaneous circulatory assist device for high-risk coronary angioplasty. Acute Card Care 10: 111–115

    Google Scholar 

  • Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. The Lancet 360:196–202

    Article  CAS  Google Scholar 

  • Freitas de Souza C De Souza Brito F et al (2010) Percutaneous Mechanical Assistance for the Failing Heart. J Interven Cardiol 23:195–202

    Article  Google Scholar 

  • Garatti A, Colombo T, Russo C et al (2006) Left ventricular mechanical support with the Impella Recover left direct microaxial blood pump: A single-center experience. Artif Organs 30:523–528

    Article  PubMed  Google Scholar 

  • Gopal S, Jayakumar D, Nelson PN (2009) Meta-analysis on the effect of dopexamine on in-hospital mortality. Anaesthesia 64:589–594

    Article  CAS  PubMed  Google Scholar 

  • Hollenberg SM (2011) Vasoactive Drugs in Circulatory Shock. Am J Resp Crit Care 183:847–855

    Article  CAS  Google Scholar 

  • Holmes CL, Walley KR (2009) Vasoactive drugs for vasodilatory shock in ICU. Curr Opin Crit Care 15:398–402

    Article  PubMed  Google Scholar 

  • Kersten JR et al (2000) Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K (ATP) channels. Anesth Analg 90:5–11

    Article  CAS  PubMed  Google Scholar 

  • Kozic DJ, Plunkett MD (2011) Mechanical circulatory support. Organogenesis 7:50–63

    Article  Google Scholar 

  • Landoni G, Mizzi A, Biondi-Zoccai G, Bruno G, Bignami E, Corno L, Zambon M, Gerli C, Zangrillo A (2010) Reducing mortality in cardiac surgery with levosimendan: a metaanalysis of randomized controlled trials. J Cardiothorac Vasc Anesth 24:51–57

    Article  PubMed  Google Scholar 

  • Landoni G, Mizzi A, Biondi-Zoccai G, Bignami E, Prati P, Ajello V, Marino G, Guarracino F, Zangrillo A (2010) Levosimendan reduces mortality in critically ill patients. A metaanalysis of randomized controlled studies. Minerva Anestesiol 76:276–286

    CAS  PubMed  Google Scholar 

  • Lehmann A et al (2003) Wirkt Levosimendan bei der operativen Versorgung des akuten Koronarsyndroms inoprotektiv? Anästhesiol Intensivmed Notfallmed Schmerzther 38:577–582

    CAS  PubMed  Google Scholar 

  • Nieminen MS, Fruhwald S, Heunks LMA et al (2013) Levosimendan: current data, clinical use and future Moiseyev VS et al. (2002) RUSSLAN Study investigators. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute mycardial infarction. A randomized placebo-controlled double blind study (RUSSLAN). Eur Heart J 23:1422–1432

    Google Scholar 

  • O’Neill WW, Kleiman NS, Moses J et al (2012) A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention. The PROTECT II Study. Circulation 126:1717–1727

    Article  PubMed  Google Scholar 

  • Pavie A, Leger P, Nzomvuama A et al (1998) Left centrifugal pump cardiac assist with transseptal percutaneous left atrial cannula. Artif Organs 22:502–507

    Article  CAS  PubMed  Google Scholar 

  • Perera D, Stables R, Clayton T et al (2013) Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation 127:207–212

    Article  PubMed  Google Scholar 

  • Pulido JN, Park SJ, Rihal CS (2010) Percutaneous Left Ventricular Assist Devices: Clinical Uses, Future Applications, and Anesthetic Considerations. J Cardiothor Vasc Anesth 24:478–486

    Article  Google Scholar 

  • Rehberg S, Ertmer C, Van Aken H, Lange M, Broking K, Morelli A, Westphal M (2007) Rolle von Levosimendan in der intensivmedizinischen Behandlung des myokardialen Pumpversagens. Anaesthesist 56:30–43

    Article  CAS  PubMed  Google Scholar 

  • Romeo F, Acconcia MC, Sergi D et al (2013) Lack of intraaortic balloon pump effectiveness in high-risk percutaneous coronary interventions without cardiogenic shock: a comprehensive meta-analysis of randomised trials and observational studies. Int J Cardiol, Epub ahead of print

    Google Scholar 

  • Russel JA (2011) Vasopressin in the management of septic shock. Crit Care 15:226–245

    Google Scholar 

  • Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook, DJ, Presneill JJ, Ayers D for the VASST Investigators (2008) Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock. N Engl J Med 358:877–888

    Article  CAS  PubMed  Google Scholar 

  • Salmenperä M, Eriksson H (2009) Levosimendan in perioperative and critical c are patients. Curr Opin Anaesthesiol 22:496–501

    Article  PubMed  Google Scholar 

  • Schmid C, Philipp A (Hrsg) (2011) Leitfaden extrakorporale Zirkulation. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Serpa Neto A et al (2012) Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and metaanalysis of nine randomized controlled trials. Crit Care 16:R154–R164

    Article  PubMed Central  PubMed  Google Scholar 

  • Sharma S, Lumley M, Perera D (2013) Intraaortic balloon pump use in high-risk percutaneous coronary intervention. Curr Opin Cardiol 28:671–675

    Article  PubMed  Google Scholar 

  • Sjauw KD, Engström AE, Vis MM et al (2009) A systematic review and meta analysis of intra-aortic pump therapy in ST-elevation myocardial infarction: should we change guidelines? Eur Heart J 30:459–468

    Article  PubMed  Google Scholar 

  • Thiele H, Lauer B, Hambrecht R et al (2001) Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 104:2917–2922

    Article  CAS  PubMed  Google Scholar 

  • Thiele H, Smalling RW, Schuler GC (2007) Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 28:2057–2063

    Article  PubMed  Google Scholar 

  • Thiele H, Zeymer U, Neumann FJ et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367:1287–1296

    Article  CAS  PubMed  Google Scholar 

  • Trost JC Hillis LD (2006) Intra-Aortic Balloon Counterpulsation. Am J Cardiol 97:1391–1398

    Article  Google Scholar 

  • Vincent JL, Su F (2008) Physiology and pathophysiology of the vasopressinergic system. Best Pract Res Clin Anaesthesiol 22:243–252

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinikum der Stadt Ludwigshafen gGmbH, Ludwigshafen

    Prof. Dr. Wolfgang Zink

Authors
  1. Prof. Dr. Wolfgang Zink
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zink, W. (2014). Kardiovaskulär wirksame Medikamente und mechanische Kreislaufunterstützung. In: Repetitorium Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-44933-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-44933-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-44932-1

  • Online ISBN: 978-3-642-44933-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation